regulatory element binding protein and dietary lipid regulation of fatty acid synthesis in the mammary epithelium.
milk triglyceride; sterol regulatory element binding transcription factor 1 cleavage-activating protein; lactation THE MAMMARY GLAND is one of three major lipid-synthesizing organs in the body; the others are liver and adipose tissue (45) . This fact was recognized by the early biochemists who used the ready availability of mammary tissue from lactating ruminants and rodents to define many of the pathways of fatty acid biosynthesis (1, 4) . However, fatty acid synthesis in the mammary gland differs from that in adipose tissue, in that saturated fatty acids with 6 -14 carbons constitute the major product of de novo fatty acid synthesis in mammary tissue (40) . Longerchain fatty acids in milk were shown to originate from the diet or from mobilization of adipose tissue triglycerides (39) ; they are generally termed "preformed" fatty acids. Although the presence of medium-chain fatty acids (MCFA) in milk had been known since the 1960s, it was not until 1978 that the mechanism was elucidated. Mammary alveolar cells contain a special enzyme, thioesterase II, that terminates fatty acid synthesis after the addition of 8 -16 carbons (21) . Mouse milk was shown to contain 15-40% MCFA, 20 -30% C:16 fatty acids (from de novo lipogenesis and preformed fatty acids), and 30 -70% preformed fatty acids with Ͼ16 carbons (41) , depending on strain and diet. ⌬ 9 -fatty acid desaturases present in the gland probably increase the proportion of C16:1 and C18:1 fatty acids but have little effect on the saturation of MCFA because of desaturase specificity (28) .
Fatty acid synthesis in the mammary gland is regulated developmentally and by dietary fat. In a particularly striking early study of incorporation of 14 C from [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glucose into fatty acids by slices obtained from the lactating rat mammary gland, Abraham and Chaikoff (1) were able to show that 40 -70% of the fatty acid 14 C was derived from glucose metabolized through the pentose phosphate shunt. Slices from the gland of a pregnant or weaned animal did not utilize carbons derived from this pathway to synthesize fatty acids, demonstrating the adaptability of this system. This and many other early studies in various species showed that fatty acid synthesis in the mammary gland is activated abruptly at the initiation of lactation. Other studies show that fatty acid synthesis is reduced by high-fat diets, although the data are somewhat confusing, because whole tissue, which contains variable amounts of adipose tissue, was used in many of these studies. A seminal study by Munday and Williamson (25) circumvented this issue; they measured fatty acid synthesis by incorporating 3 H 2 O into mammary lipid in vivo, as well as in vitro, in isolated mammary acini from lactating rats. They found that, in rats fed a diet containing 20% fat, fatty acid synthesis was reduced by 50% compared with that in rats fed a standard low-fat chow (25) . The question addressed in the present work is as follows: Is sterol regulatory element binding transcription factor (SREBF)-1 involved in developmental or fatty acid regulation of mammary lipogenesis?
In tissues that actively synthesize triacylglycerol (TAG), expression of de novo fatty acid and cholesterol synthesis genes is regulated by a small family of transcription factors called SREBFs (5) . SREBF and its regulatory (escort) protein SREBF cleavage-activating protein (SCAP) combine to regulate hepatic expression of mRNAs for the "de novo" enzymes that synthesize fatty acids and cholesterol from precursor molecules (11, 17, 30) . We previously proposed that the mouse (2) and bovine (15) mammary glands use the SCAP-SREBF regulatory system to establish de novo fatty acid synthesis and to integrate dietary regulation of lipogenic gene expression during lactation.
SREBF family transcription factors have been extensively studied in liver and hepatic cells, where systemic hormones and plasma glucose levels determine whether fatty acids are mobilized or stored (16) . The principal step by which SREBFs are regulated is migration of full-length SREBF protein from the endoplasmic reticulum to the Golgi. This process is governed by the escort protein SCAP, which shuttles inactive SREBFs to the Golgi, where the DNA-binding region is released by proteolysis into the cytoplasm, ultimately traveling to the nucleus to regulate transcription of SREBF-dependent genes. Importantly, loss of SCAP prevents migration of SREBFs to the Golgi, restricting release of the DNA-binding region and limiting transcriptional induction of SREBF-dependent genes (23) .
On the basis of our mammary gland gene expression profiles showing a dramatic increase in the mRNA-encoding enzymes of de novo fatty acid synthesis at parturition (32), we hypothesized that SREBF1c is a critical regulator of fatty acid biosynthesis in the lactating mammary epithelium. To test this hypothesis, we began our studies with quantitative real-time RT-PCR (qPCR) validation of the expression of a suite of genes that lead from mitochondrial synthesis of citrate to fatty acid synthesis and desaturation. Most of these genes are known to be regulated by SREBF1c in other tissues (17) . We then examined the formation of TAG in Srebf1c-null mice and found very minimal responses, possibly because of upregulation of Srebf1a (see Supplemental Material). To obtain a more robust decrease in SREBF activity, we utilized mice with a mammary epithelial cell (MEC)-specific deletion of SCAP to abrogate the activation of both Srebf1 isoforms. TAG production in these tissue-specific SCAP-deficient (⌬-SCAP) dams was severely compromised. Finally, we tested the hypothesis that an increase in preformed fatty acids would alter milk lipid synthesis acting through the SCAP-SREBF1c pathway. Interestingly, this treatment had no effect on the mRNA expression of our lipogenic gene suite, although the level of protein for many of these molecules was decreased. Together, our observations suggest that mammary alveolar cells employ at least two mechanisms to regulate de novo fatty acid synthesis during lactation: one at the transcriptional level, which involves SREBF1, and another at the posttranscriptional level, the mechanism of which is not well understood. Cre Ϫ and SCAP fl/fl Cre ϩ females were mated with FVB males. Day 1 of pregnancy was considered the day on which a vaginal plug was observed. Day 1 of lactation was the day on which the pups were born. Litters were standardized to six pups each for all studies. For pup growth studies, litters from both strains were combined, and pups were randomly assigned to different dams. Between 9 AM and noon daily, litters were weighed using a procedure that is standard for estimation of milk intake in mouse lactation studies (20, 26) . In studies where the glands were harvested for immunostaining or isolation of MEC, FVB pups were used to standardize the litters.
METHODS

Mouse
Dietary conditions in pup growth studies. Unless otherwise indicated, all animals were fed standard laboratory rodent chow (diet no. 2018, Teklad Animal Diets, Harlan, Madison, WI), which contains 6.2% fat (18% of kilocalories from fat). Diets with altered fat contents were obtained from Research Diets (www.researchdiets.com). The composition of the diets containing 3.9% and 60.8% kilocalories from fat (given starting on day 7 of lactation for the Srebf1c-null experiments) is shown in Supplemental Table S2 . For the SCAP experiment, the high-fat diet was Research Diet no. 12344, which is 24.6% fat by weight and 46.1% fat by calories (see Supplemental Table S3 for full composition). In this experiment, the dams receiving the high-fat diet were fed ad libitum beginning on day 17 of pregnancy. The food was replaced every 4 days to prevent spoilage.
Isolation and enrichment of MEC from whole mammary glands. Mammary digestion buffer [19.5 ml of Ham's F-12 medium (catalog no. 11765, Invitrogen/GIBCO), 30 mg of trypsin (catalog no. 840-7250, GIBCO), 60 mg of collagenase (catalog no. 1088793, Boehringer), and 0.5 ml of fetal calf serum] was prepared. The fourth and fifth mammary glands were excised, and lymph nodes were removed. Two portions, ϳ30 mg each, were snap-frozen for use as whole tissue lysates (WTLs). Scalpels (catalog no. 4-322, Miltex, York, PA) were used to dice the remaining glands into a fine paste, which was added to 5 ml of digestion buffer in a precooled 50-ml conical tube. After incubation for 45 min in a 37°C shaker at 200 rpm, the digested cell suspension was brought up to 15 ml with cold PBS and spun at Ͻ300 g for 10 min. This washing procedure was repeated three times. Half of the resulting 500 l of packed organoids was lysed in 1 ml of TRIzol (www.Invitrogen.com) for RNA analysis, and half was lysed in 500 l of "mammary gland lysis buffer" for protein analysis (see below). The isolation procedure reduced the adipocyte marker perilipin (PLIN) by 98%, indicating that the MEC were highly enriched for the epithelial cell population.
RNA isolation. TRIzol samples were homogenized using a Brinkman Polytron (www.brinkmann.com), and lysates were cleared at 13,000 g for 15 min at 4°C. RNA was isolated according to the manufacturer's protocol with the Qiagen RNeasy Mini Plus protocol (catalog no. 74134, www.qiagen.com). Total RNA was quantitated using the Nanodrop 1000 spectrophotometer (www.nanodrop.com). RNA integrity was verified using the Agilent Bioanalyzer Nanoscale Microfluidics Chip Assay (www.chem.agilent.com, 2100 Bioanalyzer). For all samples of MEC-enriched preparations, the ratio of absorbance at 260 nm to absorbance at 280 nm was Ͼ1.8. qPCR analysis. Supplemental Table S1 lists the primers and probes for genes of interest, obtained from Integrated DNA Technologies (www.IDTDNA.com). The cDNA synthesis reaction consisted of 2.0 g of total RNA in 10 l of nuclease-free water plus 1.0 l of random hexamers (50 M) and 1.0 l of oligo(dT) (0.5 g/l) incubated at 70°C for 5 min with master mix 1 containing 4 l of 5ϫ first-strand buffer (Invitrogen), 2 l of 0.1 M DTT, 1 l of 10 mM dNTP blend (Roche), 1 l of RNase inhibitor (40 U/l; Promega), and 1 l of murine leukemia virus reverse transcriptase (50 U/l; Roche) per reaction. Reaction tubes were chilled on ice and spun down. The cDNA was diluted 1:10, and 5 l were used for the qPCR (representing 50 ng of total RNA per reaction) with master mix 2 containing 12.5 l of Absolute Fast qPCR Mix-Lox Rox (www.ThermoFisher. com), 2.5 l of 10ϫ primer-probe mix (5.0 M forward, 5.0 M reverse, and 2.5 M probe), 5.0 l of nuclease-free water, and 5.0 l of 1:10-diluted cDNA per reaction. qPCR data were collected on the Applied Biosystems 7500 Fast Thermocycler (www.appliedbiosystems. com). Copy numbers were calculated using the standard curve method with a known quantity of the amplicon (1.204 e7 stepping down 5-fold to 7.70 e2). All standard curves had near-optimal slopes of Ϫ3.3, y-intercepts of ϳ40, R correlations of ϳ1, and PCR efficiencies of ϳ100%, and each target amplified within the standard curve. We have found that expression of most, if not all, housekeeping genes changes during the onset of lactation; for this reason, our results are standardized to 50 ng of total RNA.
Protein isolation/Western immunoblots. Mammary lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 2.0 mM EDTA, 50 mM NaF, 5.0 mM sodium vanadate, 1% Triton X-100, 1% deoxycholate, and 0.1% SDS] to which 0.57 mM PMSF, 20 l/ml EDTA-free inhibitor cocktail (Roche), and 1.0 mM DTT were added was used to extract proteins from the MEC-enriched lysate and WTL. Samples were homogenized using a Brinkman Polytron, and lysate was centrifuged at 13,000 g for 25 min at 4°C. Protein concentrations were determined using the Coomassie Plus Protein Assay (catalog no. 1856210, Pierce Chemical, Rockford, IL). Proteins were resolved using glycerol-based SDS-polyacrylamide gels (8 -12%). Resolved proteins were transferred to polyvinylidene difluoride membranes (Millipore), and immunoblotting was carried out using the SNAP i. Collection of milk and milk clots and analysis of milk components. For Srebf1c-null mice and their controls, milk was collected as described by Schwertfeger et al. (35) . Samples were analyzed for creamatocrit content and fatty acid composition. Milk clots were collected from the stomachs of the pups after CO 2 narcosis and frozen at Ϫ80°C. Approximately 20 mg of lyophilized milk clot were weighed into an extraction tube containing 250 g of C17:0 (triglyceride) and C19:0 (methyl ester) fatty acids as internal standards. Milk clot lipids were extracted by hexane:isopropanol extraction according to Hara and Radin (14) . Milk fatty acids were transmethylated using a dual-methylation procedure: lipid was first acid-methylated overnight at 40°C in 1% methanolic sulfuric acid and subsequently transmethylated, and fatty acids were quantitated as described for milk fat (31) . Milk clot fat concentrations were determined on the basis of dilution of the internal standard.
Immunostaining of whole tissues. Mice were anesthetized with tribromoethanol (Avertin; 1 mg/g body wt) and subjected to intracardiac perfusion with 20 ml of ice-cold PBS as described by Monks et al. (24) . Both fourth mammary glands were removed, weighed, frozen between sheets of aluminum foil in liquid nitrogen-cooled isopentane, and stored at Ϫ80°C until they were sectioned. Frozen sections were collected onto Cell Tak (BD Biosciences)-coated coverslips and fixed at room temperature inside a chamber humidified with 4% paraformaldehyde for 20 min. SREBF1 immunostaining was performed on frozen, perfused tissue with primary antibody (K10, catalog no. sc-367, Santa Cruz Biotechnology) at 1:20 dilution, after glycine (0.2%) and TX-100 (0.2%) permeabilization, NaBH4 (0.1%) quenching, and blocking with 10% donkey serum. Secondary antibodies conjugated with fluorescent probes were obtained from Invitrogen. FASN immunostaining was performed on frozen sections as described above with rabbit anti-FASN (catalog no. sc-20104, Santa Cruz Biotechnology) at 1:20 dilution.
Image capture and analysis. Images were captured on an Olympus IX81 inverted motorized microscope using Olympus objectives (total internal reflection fluorescence microscope, Plan Apo, ϫ60 oil-immersion objective, 1.45 numerical aperture, 0.15-mm WD; or U Plan Apo, ϫ100 oil-immersion objective, 1.35 numerical aperture), a 100-W mercury lamp, and a Hamamatsu ORCA IIER monochromatic charge-coupled device camera (1,344 ϫ 1,024 full chip, 6.45 ϫ 6.45 m pixel), with filter sets as follows: excitation at 360 -370 nm and emission at 420 -460 for 4=,6-diamidino-2-phenylindole, excitation at 450 -480 nm and emission at 535 nm for FITC, and excitation at 535 nm and emission at 635 nm for tetramethylrhodamine isothiocyanate (2v2, JP4). The system is controlled by SlideBook software (version 4.067, Intelligent Imaging Innovations, Denver, CO), which is also used to normalize and analyze immunofluorescence. Analysis was performed on two-dimensional sections only. A minimum of eight sections from three mice per condition were used.
Statistics. Biochemical data were analyzed using the t-test function of Excel with a one-tailed distribution and equal variance of samples. For the milk composition data, analyses were performed using the fit model procedure of JMP (version 8, SAS Institute). The statistical model accounted for the fixed effects of genotype, diet, genotype ϫ diet interaction, and day of lactation. When the effect of genotype, diet, genotype ϫ diet interaction, or day of lactation was significant, individual means were separated by Student's t-test. For all analyses, statistical significance was declared at P Ͻ 0.05.
RESULTS
Lipogenic gene expression in normal mammary gland.
Milk lipid synthesis increases severalfold with the commencement of copious milk secretion following parturition (1) . To examine the role of transcriptional level regulation of enzymes involved in fatty acid synthesis, we examined expression profiles of SREBF family members and several downstream targets with qPCR in WTL from mammary glands of pregnant and lactating mice. Figure 1A shows the expression of Srebf1a, Srebf1c, and Srebf2 from day 12 of pregnancy through day 9 of lactation. These data show that Srebf1c is the most highly expressed of these genes throughout the time course examined and that it increased ϳ2.5-fold between day 17 of pregnancy and day 2 of lactation. These findings suggest that Srebf1c is the most important of the isoforms in secretory activation.
Over the same time period, the expression of several genes that are targets of SREBF1 in other tissues was upregulated fivefold or more (Fig. 1B) , mirroring expression in a previous microarray analysis (32, 33, 42 ) (see also Supplemental Fig.  S1 ), again suggesting SREBF1 activation of the fatty acid switch. Citrate formed in the mitochondria is shuttled to the cytoplasm by the mitochondrial citrate transporter SLC25A1, where it is acted on by ACLY to produce acetyl-CoA. AcetylCoA is converted by ACACA1 (also abbreviated ACC1) to malonyl-CoA, which, in turn, is used by FASN to synthesize fatty acids. Downstream of FASN, stearoyl-CoA desaturase 2 (SCD2) inserts a single double bond into synthesized or preformed fatty acids (28) . Two additional mRNAs were quantitated: Thrsp, also known as Spot 14, and Insig1, a protein that binds SCAP in the endoplasmic reticulum. http://ajpendo.physiology.org/ decrease of de novo fatty acid synthesis specifically in the mammary gland of lactating mice (46) . All these genes showed a 2.5-to 5-fold increase in expression between day 17 of pregnancy and day 2 of lactation. Consistent with increased SLC25A1 activity, we previously measured a twofold increase in the concentration of mammary gland citrate on day 2 of lactation (32) . Together, these results suggest that coordinate upregulation of the RNAs of several de novo fatty acid synthesis enzymes by SREBF1c is an important feature of the "fatty acid switch" occurring during secretory activation in the murine mammary gland (2) .
The proportion of MCFA (chain length Ͻ16) in the milk was very low on day 1 of lactation in these FVB mice (Fig. 1C) , possibly reflecting the composition of TAG synthesized during pregnancy and discharged into the lumen of the gland at parturition. Preformed fatty acids derived from the diet or body depots (chain length Ͼ16) decreased as lactation progressed, with a concomitant increase in the de novo synthesized MCFA of ϳ15% of total on day 4 of lactation and ϳ25% of total by day 10. The proportion of C16:0 fatty acids, which are derived from de novo synthesis and preformed fatty acids, remained relatively constant during this period.
Effects of deletion of SREBF1c and targeted deletion of SCAP on the mammary gland. To test the hypothesis that SREBF1c is important for de novo lipogenesis in the mammary gland, we first investigated lactation in the Srebf1c-null mouse (see METHODS). We found only a subtle defect in lactation in these mice, possibly because the expression of Srebf1a was elevated (see Supplemental Figs. S2 and S3). It is not clear whether this small defect is local or systemic, since SREBF1c was knocked out in all tissues. Srebf1a, which has a much stronger activation domain than Srebf1c (16), may compensate for the loss of Srebf1c, except under extreme dietary conditions. We therefore adopted a different strategy to determine the role of SREBFs in regulation of de novo lipogenesis in the lactating mouse mammary gland, namely, a mammary glandspecific deletion of the SREBF escort protein SCAP, targeted specifically to the mammary epithellium. In vivo studies of liver-specific SCAP loss demonstrated lack of SREBF activation, leading to aberrant lipid homeostasis in mice (23, 30) .
To obtain mammary gland-specific deletion of SCAP, SCAP fl/fl mice were crossed with transgenic mice expressing Cre recombinase driven by the ovine ␤-lactoglobulin, a gene expressed only in the mammary epithelium (38) . The region of the SCAP genomic DNA excised by Cre recombinase contains the proximal promoter and exon 1. In this system, SCAP mRNA transcription continues, because expression is driven by a constitutive promoter (27) ; however, Cre disruption of the gene effectively reduces the translation of SCAP protein due to loss of the 5=-untranslated region. Figure 2A shows that SCAP protein is decreased ϳ70% in isolated MEC from the ⌬-SCAP mice, resulting in almost complete loss of unprocessed and mature SREBF1 from the MEC and a significant diminution in pup growth rate after day 3 (Fig. 2B) . Growth rates of pups from SCAP fl/fl Cre Ϫ and SCAP fl/ϩ Cre ϩ dams were similar to growth rate of wild-type mice (data not shown). The morphology of the mammary glands in late pregnancy and early lactation was similar in ⌬-SCAP mice and controls (see Supplemental Fig. S4 ), suggesting that the defect is biochemical, rather than developmental. Immunohistochemical analysis of nuclear staining of SREBF1 in MEC supported the conclusion the SREBF1 activity was significantly diminished in the ⌬-SCAP mice (see Supplemental Fig. S5 ). We interpret our data to mean that disruption of SCAP impairs proteolytic release of the DNAbinding region, preventing SREBF1 maturation and nuclear accumulation; this result is consistent with results of targeted deletion of SCAP in the liver (11).
On days 3 and 4 of lactation, the rate of growth of the litters fed by ⌬-SCAP dams was about half that of the controls (1.2 Ϯ 0.1 vs. 2.3 Ϯ 0.2 g/day), but the glands showed little morphological abnormality by hematoxylin-and-eosin analysis (see Supplemental Fig. S4 ). The discrepancy in growth rate continued throughout the experiment, but a significant degree of morphological abnormality was observed on day 10 (data not shown). SCAP is necessary for activation of the sterol regulatory pathway through SREBF2. Loss of this pathway, which is important for cholesterol synthesis (5) , may be at least in part responsible for the late-lactation defect observed in SCAPdeleted mice. We, therefore, confined the remaining experiments to day 4 of lactation. Failure to observe a lactation defect in heterozygous SCAP fl/Ϫ Cre ϩ dams (data not shown) indicates that only one allele of SCAP is sufficient to support adequate lactation. SCAP disruption prevents induction of mRNA for some, but not all, SREBF target genes. We predicted that SCAP disruption would decrease the proportion of MCFA in the milk as well as transcription of SREBF-dependent genes. Table 1 shows that fatty acids with Յ16 carbons were decreased ϳ25% in the ⌬-SCAP mice and those with Ͼ16 carbons were increased by a similar proportion. For RNA analysis, we avoided complications arising from the mammary gland adipose tissue by preparing MEC depleted of adipocytes (34) . This MEC population contains Յ2% of adipocyte protein found in WTL, as shown by the loss of 98% of PLIN from the MEC preparation compared with WTL (see Supplemental Fig. S6 ). Gene expression copy numbers were determined by qPCR for the SREBF family members and SREBF target genes (Fig. 3, A  and B) . There was no significant change in the amount of Srebf1a, Srebf1c, or Srebf2 mRNA between control and ⌬-SCAP MEC (Fig. 3A) , despite almost complete loss of protein for SCAP and SREBF1 (Fig. 2A) . We did, however, observe a significant reduction for some SREBF target genes in SCAP-deficient MEC, including Slc25a1 (10-fold), Fasn (5-fold), Insig1 (10-fold), Scd2 (15-fold), and Thrsp (2-fold) (Fig.  3, C and D) . Surprisingly, the mRNA for two other SREBF targets, Acly and Acaca, showed no change in expression, suggesting that their regulation in mammary cells is SREBFindependent, although these genes have been shown to be regulated by SREBF1 in the liver (17) . Together, these decreases in Fasn, Slc25a1, Scd2, Thrsp, and Insig1 identify key mRNAs, the expression of which is regulated by SREBF in MEC.
SCAP deficiency reduces protein levels of lipogenic enzymes in MEC. The observation that expression of two SREBF1 target genes, Acaca and Acly, was not altered in ⌬-SCAP MEC superscripts (a, b, c, d ) are statistically significantly different (P Ͻ 0.05). b Protein levels for ⌬-SCAP mice were significantly different from control at P Ͻ 0.005. Significant difference between mice fed high-fat and control diet:
a P Ͻ 0.05; b P Ͻ 0.005. For ⌬-SCAP mice, ACLY and FASN were not detectable on the high fat diet (n/d).
prompted us to question whether these enzymes might be regulated at the posttranscriptional level. Immunoblot analysis was conducted on the adipose-depleted MEC preparations from control and ⌬-SCAP mammary glands (Fig. 3, C and D) . Highly significant decreases in the amounts of ACLY and ACACA1 proteins were observed in ⌬-SCAP MEC, suggesting posttranscriptional regulation of these molecules. As expected from the mRNA, little SLC25A1 was detected in the ⌬-SCAP MEC; however, FASN was reduced more at the protein level than expected from observed mRNA loss. Loss of FASN was also observed in immunohistochemical analysis of mammary glands from ⌬-SCAP mice (see Supplemental Fig.  S7 ). These findings suggest that, similar to adipose tissue (37), MEC also have unique mechanisms to regulate lipogenic enzyme levels. Cumulatively, SLC25A1, ACLY, ACACA1, and FASN constitute the linear de novo fatty acid synthesis pathway, and the coordinate reduction of these proteins likely leads to a reduced ability to produce fatty acids from metabolic precursors. The combination of decreased proteins in the ⌬-SCAP mice, whether reduced due to SREBF-dependent expression or posttranscriptional regulation, resulted in ϳ25% decrease in the proportion of de novo fatty acids (Յ16 carbons) on day 4 of lactation (Table 1) .
Effect of a high-fat diet on milk lipid and mammary gland gene expression. We previously suggested that SREBF1 activation might be reduced by high-fat diets (2), since such diets would mitigate the need for the de novo lipogenic pathway. If this were the case, a high-fat diet might be expected to restore the growth performance of pups nursed by ⌬-SCAP dams. We therefore investigated the effect of a diet containing 46% kilocalories as fat on pup growth, milk lipid composition, and lipogenic gene expression. Control and ⌬-SCAP dams were given the standard rodent chow diet or the high-fat diet starting on day 17 of pregnancy. In the controls, the high-fat diet had no effect on litter growth in early lactation (Fig. 4, inset) but significantly increased litter growth ϳ20% after days 5-10 (Fig. 4A) . In the ⌬-SCAP animals, the high-fat diet increased the litter growth rate by ϳ40% overall but did not restore litter growth to the rate observed in the controls in early or late lactation.
The high-fat diet significantly depressed the proportion of MCFA, as well as C16:0 fatty acid, in the milk and increased long-chain fatty acids (Table 1 ; see Supplemental Fig. S8 ). The desaturase index for C16:0 fatty acid was also increased, suggesting that the activity of SCD2 was depressed. We therefore asked whether the high-fat diet altered the mRNA for SREBF family members or SREBF target genes. There was no change in Srebf expression, as expected from the result in Fig.  4A (see Supplemental Fig. S9) , nor, to our surprise, was the level of mRNA for the target genes altered (Fig. 4B) . For purposes of comparison, the target gene levels from control and ⌬-SCAP mice from Fig. 3 are repeated with values from mice receiving the high-fat diets interpolated in Fig. 4B . Although the mRNA levels are lower in the ⌬-SCAP animals, as we have seen, the high-fat diet decreased expression of only SCD2 in controls.
We then asked whether there was a change in the level of the protein for these enzymes. Indeed, as shown in Fig. 3 , C and D, the 46% fat diet led to a substantial reduction of SLC25A1, ACLY, ACACA, and FASN protein in MEC lysates prepared from control mice fed the high-fat diet compared with control mice fed the chow diet (Fig. 3C ). There was, however, no change in the protein for SLC25A1. Essentially, the reductions in these proteins in control mice fed the 46% fat diet were comparable to the reductions observed when SREBF-dependent transcription was lost (Fig. 3C , compare control mice fed the 46% fat diet with chow-fed ⌬-SCAP mice). Feeding ⌬-SCAP mice the 46% diet gave maximal suppression of de novo fatty acids (Table 1) with concomitant maximal loss of lipogenic enzymes. These results indicate that dietary fat regulates the abundance of lipogenic enzymes in the epithelium of the lactating mammary gland, not at the mRNA level but posttranscriptionally. This regulation seems not to be dependent on SREBF1.
DISCUSSION
We began these studies with the hypothesis that SREBF transcriptional regulation was central to regulation of fatty acid biosynthesis in MEC, as it is in the liver (9, 16) . Many elegant studies detailing SREBF activation and function in the liver and hepatic cell culture systems, coupled with our gene expression profiling studies showing that Srebf1c mRNA increased dramatically at parturition in the mammary gland, supported this hypothesis. Indeed, confirmation that several known downstream targets of SREBF1c transcriptional regulation are coordinately upregulated up to fivefold at the onset of lactation (Fig. 1 ) was also consistent with the hypothesis. To provide direct confirmation, we examined Srebf1c-null mice but found only very minor shortcomings in lactation. However, we observed significant upregulation of Srebf1a, leading us to postulate that elevated SREBF1a might compensate for the loss of SREBF1c.
To determine how complete loss of SREBF-dependent gene expression affected fatty acid biosynthesis during lactation, we then turned to the floxed SCAP mouse. Cre recombinase was driven by a mammary gland-specific promoter to deplete the SCAP molecule specifically in the luminal epithelium of the mammary gland. Disruption of SCAP significantly decreased pup growth rate, but the pups did not die. The proportion of de novo synthesized fatty acids in the milk decreased as well, but only by 25%. Together, these observations suggest that SREBF-dependent gene expression is necessary for optimal de novo lipogenesis but that SREBFs are not required to establish the basal de novo fatty acid pathway in the mammary epithelium. The mRNA and protein levels for the de novo fatty acid pathway components during lactation exhibit basal levels in ⌬-SCAP MEC. Thus this basal lipogenic program initiated at the onset of lactation is not completely dependent on SREBF1 regulation of transcription.
Factors other than SREBF that have been implicated in the transcriptional control of lipogenic genes include upstream stimulatory factors (USF) (12) , the carbohydrate response element binding protein (ChREBP) (44), SP1 and SP3 (7, 10) , and MIG12 (19) . USF and ChREBP bind to E-boxes, which are known to be present in the promoter regions of Acaca. SP1 and SP3 have been found to bind to the promoters of Acly, Acaca, and Fasn, with SP3 stimulating transcription. MIG12 increases the activity of ACACA1 by increasing its polymerization but did not increase protein translation in the liver (19) . While we readily detect the ChREBP protein by Western blot in WTLs, we found neither ChREBP protein nor its mRNA in MEC from late-pregnant and lactating mice (M. C. Rudolph and S. M. Anderson, unpublished data), suggesting that it does not regulate lipogenic genes in the lactating alveolar cell. However, lactation performance was diminished in USF-2 Ϫ/Ϫ mice (13), and a quantitative trait locus associated with milk fat content in dairy cows was found to contain a binding site for SP1 and SP3 (29) . Thus USF-2 and SP1/SP3 may be good candidates for the SREBF-independent regulation of de novo lipogenesis in the lactating gland. MIG12 is 36% homologous to THRSP, which is highly expressed in the lactating mammary gland and appears to be essential for de novo lipogenesis. MIG12 is expressed only at low levels in the mammary alveolar cell of mice (P. Ramanathan and M. C. Neville, unpublished observation) and cows (15) ; so it does not seem to be a candidate for regulation of de novo lactogenesis. The role of THRSP is unclear, but Kim et al. (19) found no evidence that it altered polymerization of ACACA1.
A final possibility is regulation of translation of de novo fatty acid synthesis enzymes by microRNA (miRNA). Very clear evidence indicates that chronic treatment of mice with miR-122 downregulates Srebf1, Fasn, Acaca, Acacb, Scd1, Acly, and other genes in the liver (8) . Recent data are beginning to identify miRNAs expressed in the mammary gland (3, 36) . Interestingly, genes associated with the gene ontology category "metabolic regulation" have been found in miRNA clusters in which expression is increased during gestation and falls or stays the same in lactation. No detailed functional tests of potentially important miRNAs have been published for the normal mammary gland in pregnancy or lactation.
Regulation of mRNA vs. protein. Our results show that preventing SREBF activation significantly attenuated mRNA levels for three key enzymes along the de novo fatty acid and TAG synthesis pathways: Slc25a1, Fasn, and Scd2. This finding provides strong evidence that SREBF1 directly regulates expression of these three genes specifically in MEC. The protein levels of FASN and SLC25A1 were reduced in parallel with their mRNAs in the ⌬-SCAP mouse (Fig. 3C) . Conversely, ACLY and ACACA protein levels declined, even though Acly and Acaca gene expression was not altered, in ⌬-SCAP MEC (Fig. 3C) . This finding suggests an independent regulatory mechanism at the posttranscriptional level. These two mechanisms are depicted in Fig. 5 : the SREBF1-dependent arm modulates expression of key biosynthetic mRNAs (Slc25a1, Scd2, and Fasn); a second mechanism regulates protein abundance independently of SREBF1 transcription (ACLY and ACACA). One possibility is that SREBF1 regulates the transcription of miRNAs that modify ACLY and ACACA translation. Whether this mechanism is totally independent of SREBF1 or whether SREBF1 acts indirectly to decrease enzyme abundance is a subject for future study.
Effect of high dietary lipid. Dietary fat has been shown to regulate hepatic lipogenesis. For example, polyunsaturated fatty acids (PUFA) suppressed the activity of SREBF1c (18), whereas saturated fats induced SREBF-1c and SREBF1a, possibly through the transcriptional coactivator peroxisome proliferator-activating coactivator-1␤ (22) . More recently, SREBF1c has been implicated in the downregulation of hepatic SLC25A1 by PUFA (6) . PUFA have also been shown to repress fatty acid synthase, possibly regulating the binding of SREBF1c and nuclear factor Y through contiguous regions in the promoter (43) . The high-fat diet we fed was formulated with corn oil that contains 62% PUFA of mostly C18:2 and 25.1% MUFA of mostly C18:1 (see Supplemental Table S3 ). The diet markedly suppressed the proportion of de novo synthesized fatty acids in milk fat by 40% in control mice and 30% in ⌬-SCAP mice; however, the mRNA for neither SREBF1c nor most of its targets was downregulated. In other words, dietary PUFA had no influence on gene regulation of de novo lipogenesis in the mammary epithelium, as it has in liver. The lack of PUFA regulation of SREBF1 targets was also observed in the Srebf1c-null mice, which consumed 3.9% or 61% dietary fat (see Supplemental Material). Even though mRNA levels were unchanged, high-fat feeding decreased MEC abundance of SLC25A1, ACLY, ACACA, and FASN proteins in control mice. It is tempting to speculate that the mechanism by which the level of these proteins is decreased in the absence of changes in the amount of their RNA is the same posttranscriptional process postulated to decrease ACLY and ACACA in the ⌬-SCAP mice (Fig. 5) . Whatever the mechanism, the results of these studies provide a framework for analysis of what appears to be a novel mechanism(s) used by the mammary epithelium to alter lipogenic enzyme levels in the presence or absence of SREBF1-dependent transcription.
Conclusion. SREBF1c and its target genes are upregulated in the mammary epithelium at the onset of lactation, when the de novo fatty acid pathway is activated to provide milk fat energy in support of the growth and development of the newborn. Use of the conditional ⌬-SCAP mouse and adiposedepleted MEC identified Slc25a1, SCP2 and Fasn as direct SREBF target genes, while Acly and Acaca were not. The finding of decreased levels of ACLY and ACACA1 protein, in the presence of sustained mRNA levels, suggests a role for additional regulatory mechanism(s) for the MEC de novo fatty acid synthesis pathway. Our data lead to the novel conclusion that the expression of de novo fatty acid pathway genes in the mammary epithelium is not regulated by diets high in PUFA, as observed in the liver; however, diet does regulate the levels of these proteins.
